Site Announcement
For the latest results and update on CytoDyn’s Phase 2 CRC trial and more, here’s a link to our April 30, 2026 investor update webinar
| Date | Form | Description | XBRL | Pages | |
|---|---|---|---|---|---|
| 02/25/20 | 4 | Statement of changes in beneficial ownership of securities |
|
1 | |
| 02/14/20 | D | Official notice of an offering of securities that is made without registration under the Securities Act in reliance on an exemption provided by Regulation D and Section 4(a)(5) under the Act. |
|
6 | |
| 02/10/20 | SEC STAFF LETTER | SEC Staff Letter |
|
2 | |
| 02/04/20 | UPLOAD | SEC-generated letter |
|
1 | |
| 02/04/20 | 4 | Statement of changes in beneficial ownership of securities |
|
2 | |
| 02/03/20 | 8-K | Current report filing |
|
38 | |
| 01/31/20 | S-3 | Registration statement for specified transactions by certain issuers |
|
46 | |
| 01/22/20 | 4 | Statement of changes in beneficial ownership of securities |
|
2 | |
| 01/22/20 | 3 | Initial statement of beneficial ownership of securities |
|
1 | |
| 01/21/20 | 8-K | Current report filing |
|
7 |
